Page last updated: 2024-10-31

naphazoline and Hypertension, Malignant

naphazoline has been researched along with Hypertension, Malignant in 1 studies

Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research Excerpts

ExcerptRelevanceReference
" The patient interview revealed consumption to supra-therapeutic dosage of an association of naphazoline and prednisolone nasal sprays."2.53[Malignant hypertension and cardiac decompensation after overuse of nasal decongestant: A case report and literature review]. ( Bontemps, H; Bourdelin, M; Le Vavasseur, O; Novais, T, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Novais, T1
Bourdelin, M1
Le Vavasseur, O1
Bontemps, H1

Reviews

1 review available for naphazoline and Hypertension, Malignant

ArticleYear
[Malignant hypertension and cardiac decompensation after overuse of nasal decongestant: A case report and literature review].
    La Revue de medecine interne, 2016, Volume: 37, Issue:6

    Topics: Adult; Heart Failure; Humans; Hypertension, Malignant; Male; Naphazoline; Nasal Decongestants; Predn

2016